Pfizer: Gram-Positive Bacterial Infections trials

The registry lists 10 Gram-Positive Bacterial Infections studies with Pfizer as lead sponsor. 0 are open to participants now and 2 have results posted.

Phase 3 6Phase 4 1No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Post Marketing Surveillance Study on LinezolidCompletedNCT01564758Results posted
• Linezolid in the Treatment of Hemodialysis Patients With Catheter-Related Gram-Positive Bloodstream InfectionsTerminatedNCT00108433Phase 3Results posted
• Open-label, Multiple-dose, Phase III Study of the Population Pharmacokinetics of I.V. Synercid in 75 Pediatric PatientsTerminatedNCT00240747Phase 3
• Study Evaluating Piperacillin-Tazobactam on Certain Bacteria in Hematology and Oncology UnitsCompletedNCT00167999
• Study Evaluating Vancomycin-Resistant Enterococci in a Hematology UnitCompletedNCT00167960
• Time To Efficacy and Onset Of Action Of LinezolidCompletedNCT00147511Phase 4
• Study Comparing Tigecycline to Imipenem/Cilastatin in Complicated Intra-Abdominal Infections in Hospitalized SubjectsCompletedNCT00081744Phase 3
• Study Evaluating Tigecycline in Selected Serious Infections Caused by Vancomycin-Resistant Enterococcus (VRE) or Methicillin-Resistant Staphylococcus Aureus (MRSA)CompletedNCT00079976Phase 3
• Antibiotic Treatment for Infections of Short Term In-dwelling Vascular Catheters Due to Gram Positive BacteriaCompletedNCT00037050Phase 3
• New Antibiotic to Treat Patients With Community-acquired Pneumonia Due to a Specific Bacteria (S. Pneumoniae Pneumonia)CompletedNCT00035269Phase 3